CA2225282A1 - Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine - Google Patents

Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine Download PDF

Info

Publication number
CA2225282A1
CA2225282A1 CA002225282A CA2225282A CA2225282A1 CA 2225282 A1 CA2225282 A1 CA 2225282A1 CA 002225282 A CA002225282 A CA 002225282A CA 2225282 A CA2225282 A CA 2225282A CA 2225282 A1 CA2225282 A1 CA 2225282A1
Authority
CA
Canada
Prior art keywords
ethyl
defined above
isochroman
alkyl
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002225282A
Other languages
English (en)
Inventor
Ruth E. Tenbrink
Michael D. Ennis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia & Upjohn Company
The Upjohn Company
Ruth E. Tenbrink
Michael D. Ennis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company, The Upjohn Company, Ruth E. Tenbrink, Michael D. Ennis filed Critical Pharmacia & Upjohn Company
Publication of CA2225282A1 publication Critical patent/CA2225282A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
CA002225282A 1995-06-30 1996-06-07 Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine Abandoned CA2225282A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US60/000,741 1995-06-30
US1123496P 1996-02-06 1996-02-06
US60/011,234 1996-02-06

Publications (1)

Publication Number Publication Date
CA2225282A1 true CA2225282A1 (fr) 1997-01-23

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002225282A Abandoned CA2225282A1 (fr) 1995-06-30 1996-06-07 Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine

Country Status (12)

Country Link
EP (1) EP0836599A1 (fr)
JP (1) JPH11509532A (fr)
AU (1) AU6252296A (fr)
BR (1) BR9609631A (fr)
CA (1) CA2225282A1 (fr)
CZ (1) CZ418597A3 (fr)
FI (1) FI974640A0 (fr)
MX (1) MX9710260A (fr)
NO (1) NO976112L (fr)
PL (1) PL324319A1 (fr)
SK (1) SK164297A3 (fr)
WO (1) WO1997002259A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
ATE458727T1 (de) 2004-05-05 2010-03-15 Hoffmann La Roche Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane
PL1831152T3 (pl) 2004-12-21 2009-03-31 Hoffmann La Roche Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT
SI1831159T1 (sl) 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
CN101119989B (zh) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 色满衍生物及其在治疗cns疾病中的用途
CA2591793A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de tetraline et d'indane, et utilisations de ceux-ci
ATE396183T1 (de) 2004-12-21 2008-06-15 Hoffmann La Roche Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
WO2007051735A1 (fr) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Dérivés d'indolylmaléimide en tant qu'inhibiteurs de protéine kinase
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
AU2007263075A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263076A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
JP2010229128A (ja) * 2009-03-05 2010-10-14 Sumitomo Chemical Co Ltd ハロゲン置換テレフタル酸ジアミド化合物、その製造方法及び該化合物を用いたハロゲン置換ベンゼンジメタノールの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
ATE182590T1 (de) * 1993-12-28 1999-08-15 Upjohn Co Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen

Also Published As

Publication number Publication date
FI974640A (fi) 1997-12-30
BR9609631A (pt) 1999-03-02
CZ418597A3 (cs) 1998-06-17
NO976112L (no) 1998-03-02
NO976112D0 (no) 1997-12-29
PL324319A1 (en) 1998-05-25
FI974640A0 (fi) 1997-12-30
WO1997002259A1 (fr) 1997-01-23
MX9710260A (es) 1998-03-29
SK164297A3 (en) 1998-09-09
JPH11509532A (ja) 1999-08-24
EP0836599A1 (fr) 1998-04-22
AU6252296A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
CA2225282A1 (fr) Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine
KR102473481B1 (ko) 강력하고 선택적인 rock 억제제로서의 락탐, 시클릭 우레아 및 카르바메이트, 및 트리아졸론 유도체
US6965036B2 (en) Intermediates for guanidine mimics as factor Xa inhibitors
EP0359418B1 (fr) 5-Indolinyl-5-bêta amidométhyloxazolidines-2-one, 3-(phényl condensé)-5 bêta amidométhyloxazolidines-2-ones et 3-phényl-azoté-5 bêta amidométhyloxazolidine 2-one
RU2159238C2 (ru) Бензофураны и способ их получения
USRE41425E1 (en) Piperazine and piperidine compounds
AU631990B2 (en) New aminopiperidine, aminopyrrolidine and aminoperhydroazepine compounds, processes for their preparation thereof and pharmaceutical compositions containing them
CA2716369C (fr) Compose de phenoxypropylamine
CA2617654A1 (fr) Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
WO1996018628A1 (fr) Composes de piperadinyle et piperazinyle anti-sida a substitution alkyle
WO2007042660A2 (fr) Dérivés de la 1-amino-phtalazine substituee, leur préparation et leur application en thérapeutique
ES2291913T3 (es) Piperidinas sustituidas como ligandos del receptor h3 de la histamina.
FI96949C (fi) Menetelmä pikornaviruksia vastaan vaikuttavien pyridatsiiniamiinien valmistamiseksi ja menetelmässä käyttökelpoiset välituotteet
BRPI0709101A2 (pt) derivados de triazolona e medicamento e agente terapêutico e/ou profilático compreendendo os mesmos
CZ283993A3 (en) Phenoxy- and phenoxyalkyl piperidines as antiviral active substances
AU645707B2 (en) Piperidine derivatives
CA2332513C (fr) Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU746721B2 (en) Chemical synthesis of morpholine derivatives
KR20160023676A (ko) RORc 조절제로서 아릴 설탐 유도체
HU204274B (en) Process for producing 4-substituted pyrazolo(3,4-d)pyrimidine derivatives and pharmaceutical compositions containing them as active components
KR101522125B1 (ko) Nk3 길항제로서의 피롤리딘 유도체
WO1999032446A1 (fr) Agent de conservation de fraicheur pour fleurs coupees
US7777048B2 (en) Processes for preparing biaryl ureas and analogs thereof
NO148747B (no) Analogifremgangsmaate til fremstilling av n-fenyl-n-(4-piperidinyl)lavere alkyl-tetrazolamider
RU2798336C2 (ru) Новые соединения для лечения инфекций млекопитающих

Legal Events

Date Code Title Description
FZDE Discontinued